Abstract
Squamous cell carcinoma (SCC) is a malignancy that arises from the prickle–squamous cell layers of the epithelium. It can metastasize to regional lymph nodes and is potentially fatal. Most patients with SCC are 60 years of age or older. The main risk factors include ultraviolet light and actinic damage. Because of its variable clinical presentation, biopsy and histological examination are required for an accurate diagnosis. The main treatment modality is surgical excision, with microscopic monitoring of the margins or Mohs’ microsurgery. The treatment of choice for secondary orbital invasion is orbital exenteration. Keratoacanthoma is considered to be a variant of SCC.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Reifler DM, Hornblass A. Squamous cell carcinoma of the eyelid. Surv Ophthalmol. 1986;30(6):349–65.
Malhotra R, Huilgol SC, Huynh NT, et al. The Australian Mohs database: periocular squamous cell carcinoma. Ophthalmology. 2004;111(4):617–23.
Cook BE Jr, Bartley GB. Epidemiologic characteristics and clinical course of patients with malignant eyelid tumors in an incidence cohort in Olmsted County, Minnesota. Ophthalmology. 1999;106(4):746–50.
Scotto J, Kopf AW, Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer. 1974;34(4):1333–8.
Green A. Changing patterns in incidence of non-melanoma skin cancer. Epithelial Cell Biol. 1992;1(1):47–51.
Lim VS, Amrith S. Declining incidence of eyelid cancers in Singapore over 13 years: population-based data from 1996 to 2008. Br J Ophthalmol. 2012;96(12):1462–5.
Kwitko ML, Boniuk M, Zimmerman LE. Eyelid tumors with reference to lesions confused with squamous cell carcinoma. I. Incidence and errors in diagnosis. Arch Ophthalmol. 1963;69:693–7.
Aurora AL, Blodi FC. Lesions of the eyelids: a clinico-pathological study. Surv Ophthalmol. 1970;5:94–104.
Maclean H, Dhillon B, Ironside J. Squamous cell carcinoma of the eyelid and the acquired immunodeficiency syndrome. Am J Ophthalmol. 1996;121(2):219–21.
Donaldson MJ, Sullivan TJ, Whitehead KJ, et al. Squamous cell carcinoma of the eyelids. Br J Ophthalmol. 2002;86(10):1161–5.
Yin VT, Merritt HA, Sniegowski M, et al. Eyelid and ocular surface carcinoma: diagnosis and management. Clin Dermatol. 2015;33:159–69.
Cook BE Jr, Bartley GB. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update. Ophthalmology. 2001;108(11):2088–98; quiz 99–100, 121
Malhotra R, James CL, Selva D, et al. The Australian Mohs database: periocular squamous intraepidermal carcinoma. Ophthalmology. 2004;111(10):1925–9.
Faustina M, Diba R, Ahmadi MA, et al. Patterns of regional and distant metastasis in patients with eyelid and periocular squamous cell carcinoma. Ophthalmology. 2004;111(10):1930–2.
McNab AA, Francis IC, Benger R, et al. Perineural spread of cutaneous squamous cell carcinoma via the orbit. Clinical features and outcome in 21 cases. Ophthalmology. 1997;104(9):1457–62.
Bowyer JD, Sullivan TJ, Whitehead KJ, et al. The management of perineural spread of squamous cell carcinoma to the ocular adnexae. Ophthal Plast Reconstr Surg. 2003;19(4):275–81.
Petsuksiri J, Frank SJ, Garden AS, et al. Outcomes after radiotherapy for squamous cell carcinoma of the eyelid. Cancer. 2008;112(1):111–8.
Inaba K, Ito Y, Suzuki S, et al. Results of radical radiotherapy for squamous cell carcinoma of the eyelid. J Radiat Res. 2013;54:1131–7.
Luxenberg MN, Guthrie TH Jr. Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues. Ophthalmology. 1986;93(4):504–10.
Couch SM, Custer PL. Topical 5-fluorouracil for the treatment of periocular actinic keratosis and low-grade squamous malignancy. Ophthal Plast Reconstr Surg. 2012;28(3):181–3.
Ross AH, Kennedy CT, Collins C, et al. The use of imiquimod in the treatment of periocular tumours. Orbit. 2010;29(2):83–7.
Marmur ES, Schmults CD, Goldberg DJ. A review of laser and photodynamic therapy for the treatment of nonmelanoma skin cancer. Dermatol Surg. 2004;30(2 Pt 2):264–71.
Rossi R, Puccioni M, Mavilia L, et al. Squamous cell carcinoma of the eyelid treated with photodynamic therapy. J Chemother. 2004;16(3):306–9.
Soysal HG, Markoc F. Invasive squamous cell carcinoma of the eyelids and periorbital region. Br J Ophthalmol. 2007;91(3):325–9.
Rowe DE, Carroll RJ, Day CL Jr. Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol. 1992;26(6):976–90.
Committee on Guidelines of Care. Task Force on Cutaneous Squamous Cell Carcinoma. Guidelines of care for cutaneous squamous cell carcinoma. J Am Acad Dermatol. 1993;28(4):628–31.
Edge SE. Carcinoma of the eyelid. In: Edge SE, Byrd DR, Carducci MA, Compton CA, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
Crawford C, Fernelius C, Young P, et al. Application of the AJCC 7th edition carcinoma of the eyelid staging system: a medical center pathology based, 15-year review. Clin Ophthalmol. 2011;5:1645–8.
Sun TM, Andrew NH, O’Donnell B, et al. Periocular squamous cell carcinoma. TNM staging and recurrence. Ophthalmology. 2015;122:1512–6.
Howard GR, Nerad JA, Carter KD, et al. Clinical characteristics associated with orbital invasion of cutaneous basal cell and squamous cell tumors of the eyelid. Am J Ophthalmol. 1992;113(2):123–33.
Goepfert H, Dichtel WJ, Medina JE, et al. Perineural invasion in squamous cell skin carcinoma of the head and neck. Am J Surg. 1984;148(4):542–7.
Cottel WI. Perineural invasion by squamous-cell carcinoma. J Dermatol Surg Oncol. 1982;8(7):589–600.
Petter G, Haustein UF. Histologic subtyping and malignancy assessment of cutaneous squamous cell carcinoma. Dermatol Surg. 2000;26(6):521–30.
Loeffler M, Hornblass A. Characteristics and behavior of eyelid carcinoma (basal cell, squamous cell sebaceous gland, and malignant melanoma). Ophthalmic Surg. 1990;21(7):513–8.
Cribier B, Asch P, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology. 1999;199(3):208–12.
Schwartz RA. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg. 2004;30(2 Pt 2):326–33; discussion 33
Hutchinson J. Morbid growths and tumours. The “crateriform ulcer of the face”, a form of acute epithelial cancer. Trans Pathol Soc Lond. 1889;40:275–81.
Donaldson MJ, Sullivan TJ, Whitehead KJ, et al. Periocular keratoacanthoma: clinical features, pathology, and management. Ophthalmology. 2003;110(7):1403–7.
Grossniklaus HE, Wojno TH, Yanoff M, et al. Invasive keratoacanthoma of the eyelid and ocular adnexa. Ophthalmology. 1996;103(6):937–41.
Leibovitch I, Huilgol SC, James CL, et al. Periocular keratoacanthoma: can we always rely on the clinical diagnosis? Br J Ophthalmol. 2005;89(9):1201–4.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rosner, M., Fabian, I.D. (2019). Squamous Cell Carcinoma. In: Pe'er, J., Singh, A., Damato, B. (eds) Clinical Ophthalmic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-030-06046-6_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-06046-6_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-06045-9
Online ISBN: 978-3-030-06046-6
eBook Packages: MedicineMedicine (R0)